Literature DB >> 20578153

Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.

Nathan A Johnson1, Jacob George.   

Abstract

The rapid emergence of nonalcoholic fatty liver disease (NAFLD) as a cause of both liver-related morbidity and mortality and cardiometabolic risk has led to the search for effective lifestyle strategies to reduce liver fat. Lifestyle intervention comprising dietary restriction in conjunction with increased physical activity has shown clear hepatic benefits when weight loss approximating 3%-10% of body weight is achieved. Yet, the poor sustainability of weight loss challenges the current therapeutic focus on body weight and highlights the need for alternative strategies for NAFLD management. Epidemiologic data show an independent relationship between liver fat, physical activity, and fitness, and a growing body of longitudinal research demonstrates that increased physical activity participation per se significantly reduces hepatic steatosis and serum aminotransferases in individuals with NAFLD, independent of weight loss. Mechanistic insights to explain this interaction are outlined, and recommendations for the implementation of lifestyle intervention involving physical activity are discussed. In light of the often poor sustainability of weight loss strategies, and the viability of physical activity therapy, clinicians should assess physical fitness and physical activity habits, educate patients on the benefits of fitness outside of weight loss, and focus on behavior change which promotes physical activity adoption.

Entities:  

Mesh:

Year:  2010        PMID: 20578153     DOI: 10.1002/hep.23711

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

1.  NAFLD: The role of exercise in treating NAFLD.

Authors:  Elena Reynoso; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

Review 2.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

Review 3.  Molecular mechanisms of fatty liver in obesity.

Authors:  Lixia Gan; Wei Xiang; Bin Xie; Liqing Yu
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 4.  Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal.

Authors:  Valerio Nobili; Arun J Sanyal
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

5.  Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease.

Authors:  Emily L Kullman; Karen R Kelly; Jacob M Haus; Ciaran E Fealy; Amanda R Scelsi; Mangesh R Pagadala; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  J Appl Physiol (1985)       Date:  2016-03-31

Review 6.  Human fatty liver disease: old questions and new insights.

Authors:  Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

8.  Effect of prolonged exercise and pre-exercise dietary manipulation on hepatic triglycerides in trained men.

Authors:  N A Johnson; D van Overbeek; P G Chapman; M W Thompson; T Sachinwalla; J George
Journal:  Eur J Appl Physiol       Date:  2011-09-14       Impact factor: 3.078

Review 9.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Pathogenesis and Prevention of Hepatic Steatosis.

Authors:  Fatiha Nassir; R Scott Rector; Ghassan M Hammoud; Jamal A Ibdah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.